Contemporary role of prostate cancer antigen 3 in the management of prostate cancer
(2011) European Urology — Vol. 60, n° 5, p. 1045-1054 (2011)
Files
Auprich-2011-Contemporaryroleof.pdf
Restricted Access - Adobe PDF
- 712.01 KB
Details
- Authors
- Abstract
- Newly discovered biomarkers ideally should prove clinical usefulness, provide additional detection, staging, and prognosis information to improve individual risk assessment, and potentially permit targeted cancer therapy.
- Affiliations
Citations
Auprich, M., Bjartell, A., Chun, F. K.-H., de la Taille, A., Freedland, S. J., Haese, A., Schalken, J., Stenzl, A., Tombal, B., & van der Poel, H. (2011). Contemporary role of prostate cancer antigen 3 in the management of prostate cancer. European Urology, 60(5), 1045-1054. https://doi.org/10.1016/j.eururo.2011.08.003 (Original work published 2011)